Resverlogix Corp. (RVX.TO)
0.11
+0.01
(+10.00%)
CAD |
TSX |
Feb 20, 16:00
Resverlogix SG&A Expense (Quarterly) : 0.5854M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Arch Biopartners, Inc. | 0.0125M |
| Biocure Technology, Inc. | 0.0004M |
| Microbix Biosystems, Inc. | 1.792M |
| Theratechnologies, Inc. | 17.33M |
| Helix BioPharma Corp. | 0.537M |